The role of peptides in blood‐brain barrier nanotechnology
- 18 December 2007
- journal article
- review article
- Published by Wiley in Journal of Peptide Science
- Vol. 14 (2) , 163-173
- https://doi.org/10.1002/psc.983
Abstract
The blood‐brain barrier (BBB) regulates the passage of molecules between the bloodstream and the brain. Overcoming the difficulty of delivery drugs to specific areas of the brain is a major challenge. The BBB exerts a neuroprotective function as it hinders the delivery of diagnostic and therapeutic agents to the brain. Here, we provide an overview of the way in which peptides and nanotechnology are being exploited in tandem to address this problem. Peptides can be used as specialised coatings able to transport nanoparticles with specific properties, such as targeting. The nanoparticle can also carry a peptide drug. Furthermore, peptides can be used in less conventional approaches such as all‐peptide nanoparticles. In summary, the combined use of peptides and nanotechnology offers tremendous hope in the treatment of brain disorders. Copyright © 2007 European Peptide Society and John Wiley & Sons, Ltd.Keywords
This publication has 102 references indexed in Scilit:
- Cationic Albumin–Conjugated Pegylated Nanoparticles Allow Gene Delivery into Brain Tumors via Intravenous AdministrationCancer Research, 2006
- N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor StructureBiochemistry, 2006
- Green chemistry and the health implications of nanoparticlesGreen Chemistry, 2006
- The role of nanobiotechnology in drug discoveryDrug Discovery Today, 2005
- Keynote review: Epithelial and endothelial barriers in human disease☆Drug Discovery Today, 2005
- Synthesis and screening of a small library of proline‐based biodendrimers for use as delivery agentsPeptide Science, 2005
- Pain and the blood–brain barrier: obstacles to drug deliveryAdvanced Drug Delivery Reviews, 2003
- Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting β-amyloid in Alzheimer's diseaseNeuroscience Letters, 2003
- Body distribution of 3HH-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after I.V. injections to miceLife Sciences, 2000
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990